These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 33147850)

  • 1. Application of Humanized Zebrafish Model in the Suppression of SARS-CoV-2 Spike Protein Induced Pathology by Tri-Herbal Medicine Coronil via Cytokine Modulation.
    Balkrishna A; Solleti SK; Verma S; Varshney A
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33147850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytometabolite profiling of Coronil, a herbal medicine for COVID-19, its identification by mass-spectroscopy and quality validation on liquid chromatographic platforms.
    Balkrishna A; Tomer M; Verma S; Joshi M; Sharma P; Srivastava J; Varshney A
    J Sep Sci; 2021 Nov; 44(22):4064-4081. PubMed ID: 34510772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronil, a Tri-Herbal Formulation, Attenuates Spike-Protein-Mediated SARS-CoV-2 Viral Entry into Human Alveolar Epithelial Cells and Pro-Inflammatory Cytokines Production by Inhibiting Spike Protein-ACE-2 Interaction.
    Balkrishna A; Haldar S; Singh H; Roy P; Varshney A
    J Inflamm Res; 2021; 14():869-884. PubMed ID: 33758527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcio-Herbal Medicine Divya-Swasari-Vati Ameliorates SARS-CoV-2 Spike Protein-Induced Pathological Features and Inflammation in Humanized Zebrafish Model by Moderating IL-6 and TNF-α Cytokines.
    Balkrishna A; Verma S; Solleti SK; Khandrika L; Varshney A
    J Inflamm Res; 2020; 13():1219-1243. PubMed ID: 33414643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory Drugs in the Management of SARS-CoV-2.
    Burrage DR; Koushesh S; Sofat N
    Front Immunol; 2020; 11():1844. PubMed ID: 32903555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer.
    Mihalopoulos M; Dogra N; Mohamed N; Badani K; Kyprianou N
    Eur Urol Focus; 2020 Sep; 6(5):1086-1096. PubMed ID: 32540268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbal plants coordinate COVID-19 in multiple dimensions - An insight analysis for clinically applied remedies.
    Zhang Y; Li Y; Wang X; Qu R; Li J; Li T; He T; Wang Z; Liu Y; Shao X; Lu T
    Int J Med Sci; 2020; 17(18):3125-3145. PubMed ID: 33173434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
    Perricone C; Triggianese P; Bartoloni E; Cafaro G; Bonifacio AF; Bursi R; Perricone R; Gerli R
    J Autoimmun; 2020 Jul; 111():102468. PubMed ID: 32317220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Antiviral, Anti-Inflammatory Effects of Natural Medicinal Herbs and Mushrooms and SARS-CoV-2 Infection.
    Shahzad F; Anderson D; Najafzadeh M
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32854262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19.
    Shah A
    Front Immunol; 2020; 11():1021. PubMed ID: 32574259
    [No Abstract]   [Full Text] [Related]  

  • 13. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
    Sallenave JM; Guillot L
    Front Immunol; 2020; 11():1229. PubMed ID: 32574272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a.
    Zhao J; Yang X; Wang C; Song S; Cao K; Wei T; Ji Q; Zheng W; Li J; Zhou X; Liu J
    Biomed Pharmacother; 2020 Sep; 129():110436. PubMed ID: 32768938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
    Theoharides TC
    Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery.
    Sternberg A; McKee DL; Naujokat C
    Curr Top Med Chem; 2020; 20(16):1423-1433. PubMed ID: 32416679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
    Giovane RA; Rezai S; Cleland E; Henderson CE
    Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies.
    Zhao M
    Int J Antimicrob Agents; 2020 Jun; 55(6):105982. PubMed ID: 32305588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.